Both in Pharmaceuticals
Pasithea Therapeutics vs Kyntra Bio
Over the past year KTTA returned −42.5% and KYNB returned −58.3%; their daily moves had a correlation of 0.05.
KTTA −42.5% KYNB −58.3%Growth of $1, one year, split-adjusted
| Metric | KTTA | KYNB |
|---|---|---|
| Price | $0.5300 | $3.96 |
| Market cap | $17.7M | $16.0M |
| Today | 0.00% | −8.12% |
| 1 month | +18.6% | −33.6% |
| 6 months | −37.6% | −44.4% |
| Year to date | −58.9% | — |
| 1 year | −35.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $45.7M | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 103.5% | 57.0% |
| Short % of float | 0.5% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).